Cargando…

Melatonin as a rational alternative in the conservative treatment of resistant hypertension

Detalles Bibliográficos
Autores principales:	Simko, Fedor, Reiter, Russel J., Paulis, Ludovit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2019
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075989/ https://www.ncbi.nlm.nih.gov/pubmed/31515506 http://dx.doi.org/10.1038/s41440-019-0318-3

Ejemplares similares

Effect of Melatonin on the Renin-Angiotensin-Aldosterone System in l-NAME-Induced Hypertension
por: Simko, Fedor, et al.
Publicado: (2018)

Peripheral and Central Effects of Melatonin on Blood Pressure Regulation
por: Pechanova, Olga, et al.
Publicado: (2014)

New Developments in the Pharmacological Treatment of Hypertension: Dead-End or a Glimmer at the Horizon?
por: Paulis, Ludovit, et al.
Publicado: (2015)

Is melatonin deficiency a unifying pathomechanism of high risk patients with COVID-19?
por: Simko, Fedor, et al.
Publicado: (2020)

Melatonin as a Potential Approach to Anxiety Treatment
por: Repova, Kristina, et al.
Publicado: (2022)

Hypertension and Cardiovascular Remodelling in Rats Exposed to Continuous Light: Protection by ACE-Inhibition and Melatonin
por: Simko, Fedor, et al.
Publicado: (2014)

Angiotensin A/Alamandine/MrgD Axis: Another Clue to Understanding Cardiovascular Pathophysiology
por: Hrenak, Jaroslav, et al.
Publicado: (2016)

Renin–Angiotensin–Aldosterone System: Friend or Foe—The Matter of Balance. Insight on History, Therapeutic Implications and COVID-19 Interactions
por: Simko, Fedor, et al.
Publicado: (2021)

Effect of Ivabradine on a Hypertensive Heart and the Renin-Angiotensin-Aldosterone System in L-NAME-Induced Hypertension
por: Simko, Fedor, et al.
Publicado: (2018)

Ivabradine Ameliorates Kidney Fibrosis in L-NAME-Induced Hypertension
por: Stanko, Peter, et al.
Publicado: (2020)

Lactacystin-induced kidney fibrosis: Protection by melatonin and captopril
por: Repova, Kristina, et al.
Publicado: (2022)

Chronodisruption: Origin, Roots, and Developments of an 18-Year-Old Concept. Comment on Desmet et al. Time-Restricted Feeding in Mice Prevents the Disruption of the Peripheral Circadian Clocks and Its Metabolic Impact during Chronic Jetlag. Nutrients 2021, 13, 3846
por: Erren, Thomas C., et al.
Publicado: (2022)

Early Treatment of Acute Myocardial Infarction with Melatonin: Effects on MMP-9 and Adverse Cardiac Events
por: Domínguez-Rodríguez, Alberto, et al.
Publicado: (2022)

Melatonin: highlighting its use as a potential treatment for SARS-CoV-2 infection
por: Reiter, Russel J., et al.
Publicado: (2022)

Sacubitril/Valsartan and Ivabradine Attenuate Left Ventricular Remodelling and Dysfunction in Spontaneously Hypertensive Rats: Different Interactions with the Renin–Angiotensin–Aldosterone System
por: Simko, Fedor, et al.
Publicado: (2022)

Melatonin: Regulation of Prion Protein Phase Separation in Cancer Multidrug Resistance
por: Loh, Doris, et al.
Publicado: (2022)

Ivabradine improves survival and attenuates cardiac remodeling in isoproterenol‐induced myocardial injury
por: Simko, Fedor, et al.
Publicado: (2020)

The realities of rationing in health care
por: Moosa, Mohammed R., et al.
Publicado: (2021)

Melatonin as a Potential Agent in the Treatment of Sarcopenia
por: Coto-Montes, Ana, et al.
Publicado: (2016)

Rational use of face masks in the COVID-19 pandemic
por: Feng, Shuo, et al.
Publicado: (2020)

Melatonin: Regulation of Biomolecular Condensates in Neurodegenerative Disorders
por: Loh, Doris, et al.
Publicado: (2021)

The Multiple Functions of Melatonin: Applications in the Military Setting
por: Gancitano, Giuseppe, et al.
Publicado: (2022)

Lactacystin-Induced Model of Hypertension in Rats: Effects of Melatonin and Captopril
por: Simko, Fedor, et al.
Publicado: (2017)

Resistant hypertension and COVID-19: tip of the iceberg?
por: Tadic, Marijana, et al.
Publicado: (2021)

Clinical Uses of Melatonin in Pediatrics
por: Sánchez-Barceló, Emilio J., et al.
Publicado: (2011)

Light, Water, and Melatonin: The Synergistic Regulation of Phase Separation in Dementia
por: Loh, Doris, et al.
Publicado: (2023)

Should we ration extracorporeal membrane oxygenation during the COVID-19 pandemic?
por: Supady, Alexander, et al.
Publicado: (2021)

Melatonin reduces lipid peroxidation and membrane viscosity
por: Reiter, Russel J., et al.
Publicado: (2014)

Editorial: Therapeutic Advances in Melatonin Research
por: López-Muñoz, Francisco, et al.
Publicado: (2022)

COVID-19: Melatonin as a potential adjuvant treatment
por: Zhang, Rui, et al.
Publicado: (2020)

Neurotoxins: Free Radical Mechanisms and Melatonin Protection
por: Reiter, Russel J., et al.
Publicado: (2010)

Melatonin: A Versatile Protector against Oxidative DNA Damage
por: Galano, Annia, et al.
Publicado: (2018)

Revisiting the diagnosis of ‘resistant hypertension’: what should we do nowadays’
por: Alsharari, Reem, et al.
Publicado: (2021)

Therapeutic perspectives in hypertension: novel means for renin–angiotensin–aldosterone system modulation and emerging device-based approaches
por: Unger, Thomas, et al.
Publicado: (2011)

The balancing act of urban conservation
por: Turo, Katherine J., et al.
Publicado: (2020)

Mechanisms of Melatonin in Alleviating Alzheimer’s Disease
por: Shukla, Mayuri, et al.
Publicado: (2017)

Melatonin and Carbohydrate Metabolism in Plant Cells
por: Arnao, Marino B., et al.
Publicado: (2021)

Melatonin: Regulation of Viral Phase Separation and Epitranscriptomics in Post-Acute Sequelae of COVID-19
por: Loh, Doris, et al.
Publicado: (2022)

Melatonin is a potential inhibitor of ovarian cancer: molecular aspects
por: Zare, Hadis, et al.
Publicado: (2019)

Melatonin in Retinal Physiology and Pathology: The Case of Age-Related Macular Degeneration
por: Blasiak, Janusz, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bgc5564mth9jht81a1ndtaagqb